Related Experiment Video
Updated: Jul 7, 2026

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
Published on: November 11, 2014
Heterogeneity in the processing defect of SLC26A4 mutants
1Department of Pharmacology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Mutations in the SLC26A4 gene cause hearing loss by disrupting pendrin protein processing. Different mutations require unique strategies for potential rescue, highlighting the need for personalized approaches to treat these conditions.
Area of Science:
- Genetics
- Molecular Biology
- Otolaryngology
Background:
- Mutations in the SLC26A4 gene are linked to Pendred syndrome and non-syndromic hearing loss (DFNB4).
- Understanding the molecular mechanisms of these mutations is crucial for developing therapeutic strategies.
Purpose of the Study:
- To analyze non-synonymous SLC26A4 mutations in East Asians and common Caucasian mutations.
- To characterize the molecular pathogenic mechanisms of these mutations.
- To explore methods for rescuing protein processing defects caused by SLC26A4 mutations.
Main Methods:
- Generated 11 non-synonymous disease-associated SLC26A4 mutations.
- Examined the effects of these mutations on pendrin protein processing.
- Assessed the impact on ion transporting activities (Cl-/HCO3- exchange).
Main Results:
- Most SLC26A4 mutations resulted in intracellular retention of pendrin, abolishing its glycosylation and ion transport functions.
- Significant heterogeneity was observed in mutant pendrin processing, cellular localization, and sensitivity to rescue treatments.
- H723R-pendrin (common in East Asians) showed ER retention, partially rescued by low temperature; L236P-pendrin (common in Caucasians) localized to the centrosome and was temperature-insensitive.
Conclusions:
- Pendrin protein processing defects are determined by mutation-specific mechanisms.
- Developing effective rescue strategies for SLC26A4-related hearing loss requires a mutant-specific approach to address individual conformational defects.
More Related Videos
11:12Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Lysosomal Hydrolases
Export of Misfolded Proteins out of the ER
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters